Elisaf MS - Search Results

1

Effects of sodium-glucose co-transporter 2 inhibitors on metabolism: unanswered questions and controversies.

Tsimihodimos V, Filippatos TD, Elisaf MS. Tsimihodimos V, et al. Among authors: elisaf ms. Expert Opin Drug Metab Toxicol. 2017 Apr;13(4):399-408. doi: 10.1080/17425255.2017.1258055. Epub 2016 Nov 17. Expert Opin Drug Metab Toxicol. 2017. PMID: 27819144 Review.

2

The effects of the addition of micronised fenofibrate on uric acid metabolism in patients receiving indapamide.

Achimastos A, Liberopoulos E, Nikas S, Bairaktari E, Miltiadous G, Tsimihodimos V, Elisaf M. Achimastos A, et al. Curr Med Res Opin. 2002;18(2):59-63. doi: 10.1185/030079902125000273. Curr Med Res Opin. 2002. PMID: 12017210

3

Combined treatment with fibrates and small doses of atorvastatin in patients with mixed hyperlipidemia.

Liamis G, Kakafika A, Bairaktari E, Miltiadous G, Tsimihodimos V, Goudevenos J, Achimastos A, Elisaf M. Liamis G, et al. Curr Med Res Opin. 2002;18(3):125-8. doi: 10.1185/030079902125000372. Curr Med Res Opin. 2002. PMID: 12094821 Clinical Trial.

4

Effects of various fibrates on serum alkaline phosphatase activity.

Ganotakis E, Tsimihodimos V, Bairaktari E, Rizos E, Athyros V, Seferiades C, Elisaf M. Ganotakis E, et al. Atherosclerosis. 2002 Nov;165(1):187-8. doi: 10.1016/s0021-9150(02)00117-x. Atherosclerosis. 2002. PMID: 12208487 No abstract available.

5

Hypouricaemia as a marker of a generalized proximal tubular damage in alcoholic patients.

Liberopoulos E, Miltiadous G, Elisaf M. Liberopoulos E, et al. Alcohol Alcohol. 2002 Sep-Oct;37(5):472-4. doi: 10.1093/alcalc/37.5.472. Alcohol Alcohol. 2002. PMID: 12217941

6

Effects of fibrates on serum metabolic parameters.

Elisaf M. Elisaf M. Curr Med Res Opin. 2002;18(5):269-76. doi: 10.1185/030079902125000516. Curr Med Res Opin. 2002. PMID: 12240789 Review.

7

Effect of ciprofibrate on lipoproteins, fibrinogen, renal function, and hepatic enzymes.

Rizos E, Bairaktari E, Ganotakis E, Tsimihodimos V, Mikhailidis DP, Elisaf M. Rizos E, et al. J Cardiovasc Pharmacol Ther. 2002 Oct;7(4):219-26. doi: 10.1177/107424840200700404. J Cardiovasc Pharmacol Ther. 2002. PMID: 12490967 Clinical Trial.

8

Starting with rosuvastatin in primary hyperlipidemia--Is there more than lipid lowering?

Milionis HJ, Gazi IF, Filippatos TD, Tzovaras V, Chasiotis G, Goudevenos J, Seferiadis K, Elisaf MS. Milionis HJ, et al. Among authors: elisaf ms. Angiology. 2005 Sep-Oct;56(5):585-92. doi: 10.1177/000331970505600510. Angiology. 2005. PMID: 16193198 Clinical Trial.

9

Serum lipoprotein(a) levels and apolipoprotein(a) isoform size and risk for first-ever acute ischaemic nonembolic stroke in elderly individuals.

Milionis HJ, Filippatos TD, Loukas T, Bairaktari ET, Tselepis AD, Elisaf MS. Milionis HJ, et al. Among authors: elisaf ms. Atherosclerosis. 2006 Jul;187(1):170-6. doi: 10.1016/j.atherosclerosis.2005.08.036. Epub 2005 Sep 28. Atherosclerosis. 2006. PMID: 16197951

10

Lipoprotein-associated phospholipase A2 activity is a marker of small, dense LDL particles in human plasma.

Gazi I, Lourida ES, Filippatos T, Tsimihodimos V, Elisaf M, Tselepis AD. Gazi I, et al. Clin Chem. 2005 Dec;51(12):2264-73. doi: 10.1373/clinchem.2005.058404. Epub 2005 Oct 13. Clin Chem. 2005. PMID: 16223884

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

527 results

Search Page

Filters